Hyperthyroidism and Graves Disease: Symptoms, Causes, and Treatment

Hyperthyroidism is a condition in which your thyroid gland produces excessive amounts of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). These hormones regulate metabolic processes, including energy consumption, heart rate, digestive metabolism, body temperature, and nutrient metabolism. 

When thyroid hormones are increased, the body’s metabolic process also increases, leading to several symptoms such as unexplained weight loss, increased hunger, irregular heartbeat, anxiety, irregular bowel movements, and many more. Additionally, over time, untreated hyperthyroidism leads to cardiovascular complications, reduced bone mineral density, and muscle wasting. 

They are opposites. Hyperthyroidism is a state of too much thyroid hormone, driving a system that won’t slow down. Hypothyroidism is a state of deficiency, i.e. too little thyroid hormone, resulting in fatigue, weight gain, cold intolerance, depression, and cognitive slowing. Both are thyroid dysfunctions, but their mechanisms, causes, and treatments differ significantly. Graves’ disease is the classic autoimmune disease of hyperthyroidism; Hashimoto thyroiditis is the classic autoimmune disease of hypothyroidism. Both involve immune attack on the thyroid but produce opposite hormonal outcomes.

Yes. Graves’ disease accounts for approximately 70 to 80% of all hyperthyroidism diagnoses globally. It is an autoimmune condition in which the immune system produces antibodies that continuously stimulate the thyroid, overriding the normal feedback loop. Unlike other causes of hyperthyroidism, such as toxic nodular goitre or thyroiditis, Graves’ disease typically presents with additional immune features, including eye involvement (Graves ophthalmopathy) and, less commonly, skin changes (pretibial myxedema). It tends to run in families and is far more common in women than men.

Graves’ disease does not arise from a single cause; it’s multifactorial, involving several causative factors such as genetic, environmental, and immunological factors. Genetic susceptibility creates a baseline risk, but environmental factors appear to pull the trigger. Also, Epstein-Barr virus reactivation is consistently linked to autoimmune thyroid disease onset. Moreover, clinical evidence suggests increased intestinal permeability and alteration in gut microbiome may contribute to immune dysregulation and result in Graves’ disease. 

However, one of the most common proposed causative mechanisms of Graves’ disease is molecular mimicry, in which microbial antigens may cross-react with thyroid tissue. Other factors, such as hormonal shifts, particularly postpartum estrogen fluctuation, are known precipitants in women. Chronic psychological stress, iodine excess, and heavy metal accumulation also figure prominently in the research literature.

Chronic stress is not a direct cause of hyperthyroidism. However, it may lead to or worsen the autoimmune thyroid disorder named Graves’ disease in genetically predisposed individuals. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis and influences disease activity by affecting immune mechanisms and the inflammatory process. Also, several observational studies show that major life stress, such as bereavement, relationship breakdown, etc., can contribute to the onset of Graves’ disease. However, stress alone is unlikely to be a sole causative factor of hyperthyroidism; it may act as one of the environmental factors contributing to the disease. Hence, it’s important to adapt the comprehensive treatment approach for Graves’ disease alongside medical care.  

However, one of the most common proposed causative mechanisms of Graves’ disease is molecular mimicry, in which microbial antigens may cross-react with thyroid tissue. Other factors, such as hormonal shifts, particularly postpartum estrogen fluctuation, are known precipitants in women. Chronic psychological stress, iodine excess, and heavy metal accumulation also figure prominently in the research literature.

Mild hyperthyroidism, particularly in early Graves disease, can respond meaningfully to a root-cause approach, including dietary change, gut repair, stress regulation, targeted supplementation, and toxin reduction. Even some clinical trials found that selenium supplements may reduce thyroid autoantibodies in Graves’ disease. However, selenium should be considered only as a supportive supplement rather than a whole treatment.  Moderate to severe hyperthyroidism requires conventional medicine for hyperthyroidism alongside natural strategies, not instead of them. As untreated or poorly managed hyperthyroidism carries real cardiovascular risk, including atrial fibrillation and bone density loss. Natural management works best as a complement to medical care, with regular monitoring of thyroid function and antibody levels.

However, one of the most common proposed causative mechanisms of Graves’ disease is molecular mimicry, in which microbial antigens may cross-react with thyroid tissue. Other factors, such as hormonal shifts, particularly postpartum estrogen fluctuation, are known precipitants in women. Chronic psychological stress, iodine excess, and heavy metal accumulation also figure prominently in the research literature.